Skip to content
Screener

AnaptysBio, Inc. ANAB Royalty Management Company — Income Tax Expense Benefit

Other segment segments

Biopharma Company
$0

Similar metrics at other companies

Bank of the James Financial Group logo
BOTJHolding Company — Income Tax Expense Benefit
$100K+279%
Icahn Enterprises logo
IEPHolding Company — Income Tax Expense Benefit
-$1M-110%
OGE Energy logo
OGEElectrics Company — Income Tax Expense Benefit
$23.8M+2.1%
Orange County Bancorp logo
OBTWealth Management — Income Tax Expense Benefit
$224K-0.9%
Trustmark logo
TRMKWealth Management — Income Tax Expense Benefit
$1.3M+42.5%
First National Corp. logo
FXNCWealth Management — Income Tax Expense Benefit
$76K+38.2%

Other financials

Income statement

See full
Revenue$25.6M-8.0%
Operating income-$34.6M-25.8%
Net income-$52.9M-34.5%
EPS (diluted)-$1.84-43.8%

Balance sheet

See full
Cash & equivalents$248.5M+152%
Total debt$13.6K-99.9%
Total equity$12.7M-62.5%
Total assets$329.7M-21.9%

Cash flow

See full
Operating cash flow-$25.9M-142%
CapEx$17.0K-51.4%
Free cash flow-$25.9M-142%

Valuation

See full
Market cap$1.62B+145%
Enterprise value$1.37B+117%
P/S+1.6×

Profitability

See full
Operating margin17.6%+9.6pp
Net margin-49.9%-22.6pp
FCF margin1.9%+1.0pp

Returns & leverage

See full
Return on equity-343.8%-1,012pp
Debt / equity-0.5×
Current ratio7.6×-0.7×

Where this comes from

Reported directly by AnaptysBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026.

Filed
May 12, 2026, 4:20 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-219515
Line itemBiopharmaRoyalty ManagementTotal
(Loss) income from operations(52,811)18,174(34,637)
Interest income2,3283252,653
Non-cash interest expense(20,859)(20,859)
Other expense, net(1)(1)
Total other income (expense), net2,327(20,534)(18,207)
Loss before income taxes(50,484)(2,360)(52,844)
Provision for income taxes(40)(40)
Segment net loss(50,484)(2,400)(52,884)

Item 1. Consolidated Financial Statements

FAQ

What is AnaptysBio, Inc.'s royalty management company — income tax expense benefit?
AnaptysBio, Inc. (ANAB) reported royalty management company — income tax expense benefit of $40K in Q1 2026.
How has AnaptysBio, Inc.'s royalty management company — income tax expense benefit changed year-over-year?
AnaptysBio, Inc.'s royalty management company — income tax expense benefit decreased by 9.1% year-over-year, from $44K to $40K.
What does royalty management company — income tax expense benefit mean?
This metric represents the total income tax provision or benefit recognized by the royalty management business segment during the reporting period. It reflects the tax impact of the segment's operational profitability and financial activities, excluding taxes allocated to other corporate divisions. Investors use this to understand the effective tax burden associated specifically with royalty-based revenue streams.

Ask your AI about AnaptysBio, Inc.'s royalty management company — income tax expense benefit.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude